The main area of OncoReview’s  scientific mission is the emerging field of interdisciplinary oncology, with particular emphasis on cardio-oncology. Scientific papers published in the journal concern modern diagnostic and therapeutic methods used in this population of patients, as well as all adverse events related to anticancer treatment. Objective assessment of the benefits and risks of new oncological drugs is a unique benefit of the published works. 

e-ISSN: 2450-6125        DOI: 10.24292/01.OR

Indexed in: 
SCOPUS: SJR = 0.125; SNIP = 0.099
                      Polish Journals Master List: 20 points 
                      Index Copernicus: 116.25                                     
                      Google Scholar
                      Polish Medical Bibliography


Vol 13 No 4(52) (2023)

Dear Readers,

This year's last issue of "OncoReview" opens with a review paper on immunotherapy, which has become another "pillar" of modern anticancer treatment. A group of young scientists led by Kamil Poboży from the Medical University of Warsaw presents the place that neoantigen vaccines may have in this branch of personalized clinical oncology.

The next two articles are descriptions of clinical cases, which are always carefully read by practicing physicians. In the first one, Pażyra et al. present a rare case of small cell lung cancer metastasizing to the eyeball.

In turn, Radziszewska et al. present a description of surgical treatment of lymphedema and lymphorrhea, which are complications of thigh sarcoma excision and radiotherapy.

I wish you interesting reading,

Radosław Grabysa, MD, PhD, Associate Professor

Published: 2024-01-09

View All Issues